CoreCivic NYSE: CXW reported stronger first-quarter 2026 results and raised its full-year outlook, citing higher demand from federal immigration authorities, the activation of previously idle facilities and the acquisition of Clinical Solutions Pharmacy.
Strong Financial Performance Driven by Facility Activations Announces Acquisition of Clinical Solutions Pharmacy Increases 2026 Full Year Guidance BRENTWOOD, Tenn., May 06, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) (CoreCivic or the Company) announced today its first quarter 2026 financial results.
BRENTWOOD, Tenn., April 01, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it will release its 2026 first quarter financial results after the market closes on Wednesday, May 6, 2026.
BRENTWOOD, Tenn., March 11, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it has received approval for a Special Use Permit (SUP) at the Company's 1,033-bed Midwest Regional Reception Center in Leavenworth, Kansas.
Turiya Advisors exited a stake in CXW during the fourth quarter, selling 479,000 shares. The quarter-end position value decreased by $9.75 million as a result of the exit.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.